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demonstrated the long-term durability of cryopreserved
allograft valve.1 Cryopreservation techniques have been
designed to maximize the viability of the endothelial
cells and connective tissue cells, based on the premise
that this viability is an important factor in maintaining
the structural integrity of these valves over prolonged
periods of time. Nevertheless, evidence that cellular
viability can be maintained in allografts implanted for
extended periods of time has not been convincing, and
morphologic studies have consistently demonstrated
that such grafts eventually become completely acellu-
lar, except for the presence of fibrous sheathing com-
posed of cells and extracellular matrix components of
host origin.2,3 The mechanism responsible for this loss
of cells has not been identified. It is known that mor-
phologic and metabolic changes consistent with hypoxic dam-
age develop during the period of time involved in har-
vesting and processing of allografts.4,5 However,
changes of a different type develop gradually in the
endothelial cells and connective tissue cells (fibroblasts
and myofibroblasts) after implantation and consist of
T he use of allografts for the replacement of diseasedcardiac valves and for the reconstruction of the right
ventricular outflow tract has increased considerably
during the last decade, and numerous studies have
Objective: The purpose of this study was to determine whether apoptosis
of endothelial and connective tissue cells is responsible for the loss of cel-
lularity observed in implanted aortic allograft valves. Methods: Fresh (n
= 6) and cryopreserved (n = 4) aortic allograft valves were retrieved at 2
days to 20 weeks after implantation in an ovine model. Sections of these
valves were studied with the use of histologic and electron microscopic
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VIII–related antigen and proliferating cell nuclear antigen, followed by
counterstaining for DNA and laser scanning confocal fluorescence
microscopic observation. Results: The endothelial cells and cusp connec-
tive tissue cells of implanted valvular allografts showed loss of prolifer-
ating cell nuclear antigen (indicative of cessation of mitotic activity) and
evidence of apoptosis (nick end labeling). The latter was manifested by
nuclear condensation and pyknosis, positive nick end labeling, and for-
mation of intra- and extracellular apoptotic bodies derived from the
fragmentation of apoptotic cells. These changes began to develop at 2
days after implantation, peaking at 10 to 14 days, and became complete
by 20 weeks, at which time the valves had the typical acellular morpho-
logic features of allografts implanted for long periods of time.
Conclusions: Apoptosis occurs in endothelial cells and cuspal connective
tissue cells of implanted allografts and appears to be a cause of their loss
of cellularity. This apoptosis may be related to various factors, including
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and reperfusion injury at the time of implantation. (J Thorac
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severe nuclear pyknosis.2,3 This pyknosis is followed
by a gradual loss of cellularity and is morphologically
similar to the nuclear condensation that is characteris-
tic of the initial phase of apoptosis.6 We initiated the
present study to evaluate the possibility that apoptosis
is responsible for the loss of cell viability observed in
fresh and cryopreserved allografts implanted in an
ovine model. For this purpose, we have used electron
microscopy, in situ nick end labeling, and immunohis-
tochemical techniques in conjunction with confocal
laser scanning fluorescence microscopy.3
Methods
Animal model. Both the donor and the recipient sheep
were of the Dorset breed and were 4 months old, with a body
weight of 38 to 40 kg at the time of the allograft harvesting
and implantation. The investigational protocol used in this
study was approved by the Animal Use and Care Committee
of the Georgetown University Medical Center, and the ani-
mals received humane care in compliance with the principles
stated in the Guide for Care and use of Laboratory Animals
(NIH Publication No. 85-23). Immediately after death, with-
in 1 minute of cardiac arrest, the entire heart was rapidly
excised and immersed in cold saline solution (warm ischemic
interval, approximately 1 minute for both the fresh and the
cryopreserved allografts). The aortic root was then excised,
with the heart and great vessels immersed in cold saline solu-
tion (as is done during the harvesting of human allograft
valves) and either placed in RPMI 1640 medium at 4°C for up
to 1 hour (fresh allograft) or disinfected and cyropreserved.
The disinfection and cryopreservation protocols were identi-
cal to those used clinically.7 Disinfection was accomplished
with the following antibiotics: cefoxitin, 240 m g/mL; lin-
comycin, 120 m g/mL; polymyxin B, 100 m g/mL; and van-
comycin, 50 m g/mL, in RPMI 1640 medium. The aortic
valves were immersed in the antibiotic-containing medium
for 24 hours at 4°C. The disinfected valves were subsequent-
ly transferred to RPMI 1640 medium containing 10%
dimethylsulfoxide and 10% fetal calf serum and frozen at a
controlled rate of –1°C per minute to between –40°C and
–80°C. The valves were then stored in liquid nitrogen vapor
(–190°C to –150°C) until used. Fresh and cryopreserved
sheep aortic allograft valves were implanted in the mid-tho-
racic aorta (left thoracotomy, fourth intercostal space) by
means of proximal and distal end-to-end anastomoses after
the temporary placement of a bypass shunt (to prevent spinal
cord ischemia/paraplegia). A 5-mm expanded polytetrafluoro-
ethylene vascular graft served as a shunt between the distal
aortic arch (approximately 2-cm proximal to the allograft
anastomosis) and the left atrium. The use of this shunt raised
the left atrial pressure to approximately 12 to 14 mm Hg but
did not result in the subsequent development of congestive
heart failure in chronic (20 weeks) animals. The shunt served
to increase the aortic pulse pressure by decreasing the dias-
tolic pressure (eg, 10-15 mm Hg). The intraoperative peak
diastolic pressure measured in the aorta, proximal to the allo-
graft, with a cardiac output of 3 L/min, typically varied
between 50 and 70 mm Hg. The placement of this shunt pro-
vided the appropriate hemodynamic conditions necessary to
ensure the full range of leaflet motion and coaptation, as con-
firmed by Doppler echocardiography. The cusps were ob-
served to simply flutter throughout the cardiac cycle when the
aortic-left atrial shunt was crossclamped or occluded.
Included in this study were 15 sheep aortic valves: 5 native,
unimplanted valves and 10 explanted allograft valved con-
duits. Six of these allografts were fresh, and the other 4 were
cryopreserved. All animals were electively killed. Our inves-
tigational plan was designed to implant the long-term (20
weeks) allografts first and conduct the initial explant patho-
logic studies to assess the suitability of this experimental
model. After the first series of 20-week explants revealed that
the cusps were essentially acellular, we modified the investi-
gational plan, focusing our efforts on short-term explants, in
the hope of capturing morphologic information that would
provide an explantation for the relatively rapid loss of cuspal
cellularity. The explanted allografts were studied after 2 days
(fresh [n = 1] and cryopreserved [n = 1] ), 8 days (cryopre-
served [n = 1]), 10 days (cryopreserved [n = 1]), 14 days
(fresh [n = 1]), 30 days (cryopreserved [n = 1]), and 20 weeks
(fresh [n = 4]) of implantation. 
Morphologic studies. Blocks of tissues fixed with phos-
phate-buffered 10% formalin were cut from the central third
of the valve, extending from the base to the free edge, and
were embedded in paraffin. From 20 to 30 consecutive sec-
tions of these blocks were used for histologic study and for
the immunohistochemical staining procedure described later.
For histologic study, the sections were stained with hema-
toxylin and eosin and Movat pentachrome stain. For
immunohistochemical study, representative sections were
stained for the simultaneous demonstration of (1) nick end
labeling for the detection of apoptosis, by means of the incor-
poration of either fluorescein-labeled or biotinylated
deoxynucleotides by terminal deoxynucleotidyl transferase
(ApopTag direct in situ apoptosis detection kit [fluorescein-
labeled deoxynucleotides] catalog S7160-Kit; Oncor, Inc,
Gaithersburg, Md; TACS-2, peroxidase kit; Trevigen,
Gaithersburg, Md); (2) dual labeling for the simultaneous
demonstration of factor VIII-related antigen (rabbit polyclon-
al antibody (DAKO Corp, Carpenteria, Calif), using a fluo-
rescein isothiocyanate-conjugated secondary antibody
(Vector Laboratories, Burlingame, Calif) and proliferating
cell nuclear antigen (PCNA; antigen retrieval heating for a
total of 15 minutes at 90°C), in conjunction with a mouse
monoclonal antibody (DAKO), using Texas red-conjugated
secondary antibody, (Vector); and (3) DNA, using a 0.01%
aqueous solution of 2,6´-diamidino-4-phenylindole (DAPI;
Sigma Chemical Co, St Louis, Mo). Appropriate negative his-
tochemical control procedures (omission of the primary anti-
body and substitution of normal goat or rabbit IgG for the pri-
mary antibody) were used in conjunction with each of these
methods and gave negative results. Simultaneous 3-color flu-
orescence imaging (fluorescein, green; Texas red, red; and
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DAPI, blue) was accomplished with a laser scanning confo-
cal fluorescence microscope (model TCS-4D-DMIR-BE;
Leica, Heidelberg, Germany). For transmission electron
microscopy (JEOL 100CX; JEOL USA, Peabody, Mass),
valve tissues were fixed with glutaraldehyde and processed as
previously described.8
Results
Histologic observations. The following histologic
findings were similar in explanted fresh and cryopre-
served allograft valves:
1. a marked reduction in cusp cellularity, which
occurred within the first 30 days of implantation
(Fig 1, A and B) and was associated with conden-
sation, pyknosis, and fragmentation of the nuclei
(Fig 1, C);
2. an increase in cuspal thickness, primarily because
of the formation of a fibrous sheath of host origin
that initially consisted of a proteoglycan-rich
matrix, fibroblasts, myofibroblasts, and a lining
layer of endothelial cells (Fig 1, D);
3. infiltration of macrophages, which were diffusely
distributed in the extracellular matrix and most
numerous in valves implanted for 30 days or longer;
4. lymphocytes and plasma cells, which were rarely
observed;
5. consistent loss of the continuity of the endothelial
cell layer of the cusp;
6. progressive disruption of the structure of the
cusps, with loss of the normally distinct bound-
aries between the ventricularis and the spongiosa
after 30 days and 20 weeks of implantation,
respectively (compare Fig 1, A, B, and D);
7. extensive mineralization of the aortic walls, with-
out calcification of the cusps. 
At 20 weeks, the cusps were markedly thickened and
contracted because of extensive cellularity and deposi-
tion of collagen in fibrous sheaths (Fig 1, D). At this
time, prominent regions of collagen straightening (elon-
gation) without evidence of collagen fibril fracture had
developed in the connective tissue of the cusp.
Significant thickening and contraction of the fibrous
sheaths resulted in either valvular insufficiency or com-
plete immobilization of the cusps against the aortic wall. 
As mentioned earlier, lymphocytes and plasma cells
were rarely seen. However, in a single explant, focal
infiltrates of lymphocytes and plasma cells were
observed within the fibrosa near the cuspal surface and
deep within the cusp. This finding was not observed in
any of the other explanted valves in this series.
Immunohistochemical observations. A marked
reduction in the mitotic activity of leaflet cells occurred
within 2 days of implantation, as assessed by the loss
of the PCNA reactivity normally present in the valvu-
lar endothelial cells and connective tissue cells (Fig 1,
E and F; Fig 2, A). Staining for factor VIII (Fig 1, F)
confirmed the loss of endothelial cells from the cusp
surfaces. The endothelial cells of donor origin were
focally present on the cusp surfaces through 10 days
after implantation but were rarely seen after 30 days.
Reactivity for PCNA was rarely seen after 30 days of
implantation (Fig 2, B) and was essentially negative at
20 weeks. The very low reactivity for PCNA in the
fibrous sheath indicates that both the endothelial cells
and the myofibroblasts (both of host origin) stabilized
after a rapid, initial increase in number. 
Nick end labeling. The frequency of nick end label-
ing in endothelial cells and connective tissue cells in
unimplanted allografts was extremely low. However,
apoptosis, as demonstrated by nick end labeling, was
observed in both of these cell types at two days after
implantation (Fig 2, C) and reached a peak between 10
and 14 days (Fig 2, D), resulting in nuclear fragmenta-
tion and the formation of numerous extracellular and
intracellular apoptotic bodies by 30 days of implanta-
tion (Fig 2, E and F). Based on light microscopic mor-
phologic findings, the apoptotic-positive cells were
confined to the cuspal fibroblasts and endothelial cells
and not inflammatory cells. The apoptotic cells and/or
apoptotic bodies were present in all cuspal regions and
a selective distribution was not observed. Apoptotic-
positive cells were not observed in the fibrous sheath
encapsulating the cusp after 20 weeks of implantation.
Fibrous sheathing was not present on the cuspal sur-
faces at the time of the highest incidence of apoptosis
but only observed after 20 weeks of implantation, at a
time when the cusp was essentially acellular. 
Transmission electron microscopic observations.
Apoptotic bodies were not observed at 20 weeks.
Changes of apoptosis were most clearly demonstrated
by means of the nick end labeling techniques and con-
focal microscopy (Fig 2, C and F) and were also rec-
ognized in hematoxylin and eosin–stained sections (Fig
1, C) and by transmission electron microscopy. Trans-
mission electron microscopy was useful in evaluating
the occurrence of pyknosis (Fig 3, A) and apoptotic
bodies (Fig 3, B) and the changes in the crimping of the
valvular collagen (Fig 3, C and D). 
Discussion
In the present study, the histopathologic and histo-
chemical changes observed after implantation of ovine
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Fig 1. A, Characteristic histologic appearance of a native aortic valve. Three distinct regions are present: the ven-
tricularis (v), the spongiosa (s), and the fibrosa (f). (Hematoxylin and eosin stain; original magnification, · 100.)
B, Histologic section of a cryopreserved aortic allograft valve depicts the loss of the trilaminar structure of the
cusp after 30 days of implantation. Loss of endothelial cells and a marked reduction in cusp cellularity are appar-
ent. (Hematoxylin and eosin stain; original magnification, · 100.) C, Cryopreserved allograft valve 30 days after
implantation. Light micrograph shows pyknotic nuclei and apoptotic bodies in cells having increased cytoplas-
mic eosinophilia (arrowhead). (Hematoxylin and eosin stain; original magnification, · 900.) D, Light micrograph
of a fresh allograft valve implanted for 20 weeks demonstrates a marked loss of cusp cellularity. The cusp is com-
pletely encased by a thick fibrous sheath. (Movat pentachrome stain: elastic fibers, black; cellular components,
red; proteoglycans, blue; collagen, yellow; mixture of proteoglycans and collagen, blue-green. Original magnifi-
cation, · 100.) E, Native aortic valve. Confocal image shows PCNA-positive nuclei (green fluorescence) in myofi-
broblasts and endothelial cells. (Original magnification, · 400.) F, Native aortic valve. High magnification con-
focal image depicts factor VIII-positive endothelial cells (red cytoplasmic fluorescence) lining the surface of the
fibrosa. Note the PCNA-positive nuclei (green fluorescence). (Original magnification, · 1000.)
4-C
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Fig 2. A, Cryopreserved allograft valve after 2 days of implantation. Confocal image demonstrates a marked
reduction in the number of PCNA-positive nuclei (green fluorescence) in the spongiosa and ventricularis.
(Original magnification, · 1000.) B, Cryopreserved allograft valve implanted for 30 days. Confocal image demon-
strates the absence of PCNA-positive nuclei (green fluorescence) and endothelial cells lining the surface of the
fibrosa. Note the low level of autofluorescence in the extracellular matrix of the cusp. Compare with Fig 1, E and
F. (Original magnification, · 400.) C, Cryopreserved allograft valve 2 days after implantation. Confocal image
shows an apoptotic nucleus (nick end labeling; green fluorescence). Cusp cellularity within the fibrosa is normal,
and nonapoptotic nuclei are demonstrated by staining with DAPI (blue fluorescence). (Original magnification,
· 400.) D, Fresh allograft valve 14 days after implantation. Nick end labeling demonstrates apoptotic nuclei
(black; peroxidase-labeling) in the spongiosa. Nonapoptotic nuclei have been counterstained with hematoxylin
stain. (Original magnification, · 630.) E, Cryopreserved allograft valve 30 days after implantation. High magni-
fication view of apoptotic nuclei and apoptotic bodies stained black by the peroxidase method for nick end label-
ing. (Original magnification, · 1000.) F, Cryopreserved allograft valve implanted for 30 days. Apoptotic, pyknot-
ic nuclei (nick end labeling; green fluorescence) and intracellular apoptotic bodies (arrowhead) are present in the
ventricularis. Cusp cellularity is decreased, as demonstrated by nuclear counterstaining with DAPI (blue fluores-
cence). Elastic fibers in the ventricularis show moderate yellow autofluorescence. (Original magnification, · 400.)
4-C
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aortic allograft valves were similar to those reported in
human allograft valves that were used as replacement
heart valves or for cardiac reconstruction.2 The follow-
ing findings indicated that apoptosis occurs in the
endothelial cells and connective tissue cells of implant-
ed allograft heart valves: (1) nuclear condensation,
pyknosis, and fragmentation; (2) formation of intra-
and extracellular apoptotic bodies, identified by their
typical ultrastructural morphologic features and their
histochemical reactivity; (3) nick end labeling; and (4)
the absence of a significant inflammatory response.6
These changes were much more obvious in the con-
nective tissue cells than in the endothelial cells,
because many of the latter cells were becoming
detached from the cusp surfaces. These findings sug-
gest that apoptosis contributes to the observed loss of
cellularity in explanted aortic allograft valves. 
Apoptosis (programmed cell death) is a form of cell
Fig 3. A, Cryopreserved allograft valve implanted for 30 days. Ultrastructural appearance of pyknotic endothe-
lial cell lining the fibrosa. Note marked condensation of the nuclear chromatin and contraction of the cytoplasm.
Compare with the normal chromatin of adjacent fibroblasts. (Uranyl acetate/lead citrate stain; original magnifi-
cation, · 4800.) B, Cryopreserved allograft valve implanted for 30 days. Transmission electron micrograph of a
macrophage contains a phagocytosed apoptotic body composed of fragmented nuclear chromatin. (Uranyl
acetate/lead citrate stain; original magnification, · 10,000.) Transmission electron micrographs depict changes in
the crimping of collagen in the cusps of (C) cryopreserved allograft valves after 30 days of implantation and (D)
fresh allograft valves after 20 weeks of implantation. Collagen crimp is preserved at 30 days, although prominent
regions of collagen straightening are noted at 20 weeks. (Uranyl acetate/lead citrate stain; original magnification,
[C] · 3500 and [D] · 2900.)
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death that plays an important role not only in the nor-
mal growth and remodeling of organs but also in nor-
mal cell renewal and in a wide variety of pathological
conditions.6,9,10 The process of apoptosis initially
involves the activation of endonucleases that cleave
DNA into fragments of specific sizes, known as
oligonucleosomes.6 These DNA fragments can be
detected by the nick end labeling techniques used in the
present study. Apoptosis can be promoted or inhibited
by a variety of modulating factors, some of which are
specific for individual cell types.6,9,10 We are not aware
of previous studies of the occurrence of apoptosis in
cardiac valvular endothelial cells or connective tissue
cells. Nevertheless, it is well established that apoptosis
does occur in both of these types of cells in other loca-
tions.6 In apoptosis, the initial changes of nuclear and
cytoplasmic condensation are followed by the frag-
mentation of nuclei and the formation of apoptotic bod-
ies containing remnants of nuclear material. Thus
apoptosis differs from cell necrosis, in which the cell
death is associated with cytoplasmic swelling, karyoly-
sis, marked inflammatory reaction, and fibrosis. In con-
trast, the remnants of apoptotic cells are phagocytosed
by adjacent parenchymal cells or by macrophages,
leaving no inflammatory reaction, cellular residue, or
fibrous scarring.6 At least in embryonic and neonatal
tissues, this process can be completed within 2 to 3
days.6,9
Although the time course of the apoptosis occurring
in individual endothelial cells and connective tissue
cells was not determined in the present study, we first
observed evidence of apoptosis (nuclear condensation
and nick end labeling) within 2 days of implantation. It
peaked at 10 to 14 days and resulted in a marked loss
of cellularity, which was complete by 20 weeks.
Therefore it would appear that the apoptosis in allo-
graft valves proceeds at an unusually slow rate (as
shown by the maximal occurrence of apoptotic bodies
at 30 days). The reason for the slow time course of this
apoptosis is not clear; however, the connective tissue
cells present in the cusp are very few in number, are
widely separated from each other, and have a very lim-
ited phagocytic capacity. These characteristics suggest
that the removal of apoptotic cells may be very slow in
valvular tissues. 
Of special interest in the context of these observa-
tions are the recently reported comparisons of the
histopathologic findings in explanted human cryopre-
served allograft valves and in the aortic valves of ortho-
topically transplanted hearts.2 The explanted aortic
allograft valves showed the usual changes of nuclear
pyknosis and loss of cellularity; however, the valves of
transplanted hearts retained their normal morphologic
features, even in the presence of fatal allograft rejec-
tion. These results can be interpreted as suggesting that
apoptosis develops in allograft heart valves, but not in
the valves of the orthotopically transplanted hearts. It is
possible that immunologic phenomena related to rejec-
tion play a role in the occurrence of apoptosis in allo-
graft valves and that this apoptosis may be prevented
by the immunosuppressive treatment administered to
patients undergoing heart transplantation. Apoptosis of
cardiac myocytes has been implicated in the rejection
of transplanted hearts,11 but no data are available con-
cerning the occurrence of this alteration in the valves of
such hearts. Thus detailed studies are needed to clarify
the possible role of immunologic injury in triggering
apoptosis in allograft valves. 
In considering various other causes of apoptosis in
allograft valves, the period of hypoxia related to the
procurement, disinfection, and cryopreservation of the
aortic allograft valves is an important factor to be eval-
uated.4,5,7 Such a period of hypoxia does not occur dur-
ing the procurement of heart allografts. 
Apoptosis can be triggered and modulated in the
heart by a variety of causes, including hypoxia and
ischemia plus reperfusion.12 Reactive oxygen species,
dimethyl sulfoxide, calcium ionophores, calcium
calmodulin, and the expression of Fas antigen have
been suggested as factors triggering the apoptosis of
cardiac myocytes.12 Allograft heart valves are exposed
to both hypoxia (during harvesting, processing, and
storage) and reperfusion-reoxygenation (at the time of
implantation and thereafter). However, valvular con-
nective tissue cells, and endothelial cells appear to be
much less sensitive than cardiac myocytes to hypox-
ia.12 An initial decrease in cusp cellularity can be attrib-
uted to direct and irreversible hypoxic injury and sub-
sequent cell death; however, the cusp cells that have
survived the initial hypoxic insult and subsequent tis-
sue processing remain ultrastructurally intact.4
Nevertheless, it is possible that subtle hypoxic injury
predisposes to the development of apoptosis when the
valves are implanted and “reperfused” with oxygenat-
ed blood. The possibility that dimethyl sulfoxide pro-
motes apoptosis in cryopreserved valves must be given
careful consideration. This agent can either pro-
mote13-21 or decrease22-24 apoptosis, depending on its
concentration and on the type of cells to which it is
applied. One study13 has suggested that concentrations
of dimethyl sulfoxide in excess of 2% definitely
increase the frequency of apoptosis. These data have
been obtained on noncardiac tissues, and for this reason
it is not known how they apply specifically to allograft
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valves. The findings reported in our study suggest that
dimethyl sulfoxide and subsequent cryopreservation
might not be responsible for initiating apoptosis,
because similar findings were observed in both the
fresh and the cryopreserved allograft valves. The initi-
ation of apoptosis during allograft harvesting, disinfec-
tion, and cryopreservation is suspected, because both
fresh and cryopreserved allografts are essentially acel-
lular after 20 weeks of implantation in our animal
model and in human allografts.2 It remains to be deter-
mined whether or not the mechanisms responsible for
inducing apoptosis differ in fresh and cryopreserved
allograft valves.
We have not tested, in an isolated and controlled
fashion, the multiplicity of factors that could be respon-
sible for our observation of apoptosis occurring in both
fresh and cropreserved allograft valves. However, our
observation does indicate that a continuum of apoptotic
changes occurs after implantation in the allograft cus-
pal cell population. Additional studies addressing the
contribution of mechanisms other than apoptosis, such
as immune-mediated mechanisms of cell death and
ischemic injury, are needed to definitively identify the
pathologic mechanism responsible for the loss of allo-
graft cuspal cellularity. 
In conclusion, the demonstration of apoptosis-medi-
ated cell death, as presented in this study, suggests that
multiple factors associated with the harvesting, pro-
cessing, and implantation of both fresh and cryopre-
served allograft valves may, in fact, contribute to the
initiation of apoptosis and the demise of cuspal con-
nective tissue cells and endothelial cells. Systematic
examination of the possible contributions of factors that
promote or inhibit apoptosis is necessary to develop
new techniques for the preservation of cellular viabili-
ty in valvular allografts and other tissue implants. 
We thank Ms Carolyn Jane Bell, National Heart, Lung and
Blood Institute, National Institutes of Health, Bethesda, Md,
for her editorial assistance with this article and Life Net
(Virginia Beach, Va) for the ovine cryopreserved aortic valve
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